0
Editor's Correspondence |

Loss of Nocturnal Blood Pressure Fall in Patients With Renal Impairment—Reply

Michael B. Davidson, DO; Daniel J. Brotman, MD
Arch Intern Med. 2006;166(19):2159. doi:10.1001/archinte.166.19.2159.
Text Size: A A A
Published online

Extract

In reply

We appreciate the insightful comments of Ben-Dov and Bursztyn and Portaluppi regarding our recent investigation of the association of nondipping with a subsequent decline in glomerular filtration rate (GFR).

Ben-Dov and Bursztyn provide evidence to suggest that nondipping may be a subtle manifestation of early nephropathy and may be amenable to reversal by agents that address “salt-sensitive” states, namely diuretics, as opposed to inhibitors of the renin-angiotensin-aldosterone (RAAS) system as we suggested. This is a possibility that we cannot dispute. Creatinine-based GFR formulas are imperfect and we lacked urine microalbumin measurements in most of our patients, so it is plausible that nondipping may have resulted from occult baseline nephropathy in some of our patients. Furthermore, given recent data suggesting that much of the renoprotection conferred by blockade of the RAAS comes from BP reduction rather than pathway-specific glomerular protection,1 diuretics may be an effective first-line treatment in hypertensive nondippers based on their established efficacy for treating hypertension in general. However, we do not agree with the notion that nondipping itself contributes to a decline in GFR or that the BP pattern itself is a therapeutic target.2 Instead, we suggest that nondipping is a marker of disrupted vascular homeostasis, likely due in large part to disrupted autonomic regulation, and that correction of the BP pattern itself need not be a goal of treatment. Mechanistically, the association of nondipping with insulin resistance,3 the ability of RAAS blockade to increase insulin sensitivity,4,5 and the sympatholytic effect of RAAS blockade in patients with nephropathy6 all support our recommendation for angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the treatment of hypertensive nondippers who respond suboptimally to lifestyle modifications.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();